Robert E. Gross MD, PhD
Departments of Neurosurgery, Neurology, Biomedical Engineering, and Neuroscience
Director and Co-Founder
Emory Neuromodulation and Technology Innovation Center (ENTICe)
Functional, Stereotactic & Epilepsy Surgery Division
Translational Neuroengineering Laboratory
Additional Contact Information
101 Woodruff Circle
Atlanta, GA 30322
Robert E. Gross earned his MD and PhD from Albert Einstein College of Medicine in New York, where he also completed his neurosurgical residency. Dr. Gross is fellowship-trained in functional and stereotactic neurosurgery (University of Toronto and The Toronto Hospital) and epilepsy surgery (Yale University and Yale/New Haven Hospital). In 2001, Dr. Gross joined the faculty of Emory University, where he currently serves as Associate Professor in the Departments of Neurosurgery and Neurology.
Dr. Gross is active in organized neurosurgery, holding a variety of positions in national and insitutional neurological societies.
In July of 2007, Dr. Gross, along with Steve M. Potter, Ph.D. of the Department of Biomedical Engineering at the Georgia Institute of Technology and Emory University, was the recipient of a prestigious grant from The Epilepsy Research Foundation (ERF) for translational research funding awards supporting innovative epilepsy products. The grant supports the development of a novel electrical stimulation approach that directly controls the activity of the brain to attain a more stable state from which seizures will not arise.
Dr. Gross’s research interests include: restorative approaches (including cell and gene therapy) for Parkinson's disease and other neurodegenerative disorders; physiology of movement disorders (Parkinson's disease, tremor, dystonia); novel surgical techniques for epilepsy (e.g. deep brain stimulation, cell and gene therapy). In particular, he has been elucidating the role of axon guidance molecules in the development and reconstruction of the nigrostriatal pathway, which degenerates in P.D. This approach, which encompasses molecular and cellular engineering in combination with neurotransplantation, may be generally useful in reconstructive approaches for many types of nervous system degeneration and injury.
- View publications on PubMed